KUMAR NEIL (See Remarks) sold 2.0% of their position (10K shares) of BRIDGEBIO PHARMA, INC. on the open market
Open‑market sale worth $690.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/21/2026ACC: 0001470831-26-000897
DirectorOfficer· See Remarks
Since Jun 2019
-10K
Net shares
Net seller
$690.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−8.72K
Price / share
$69.01
Trade value
$601.87K
% of position
1.7%
9/17/2026
505.69K→496.96K
Common Stock
Indirect
Shares
−1.28K
Price / share
$69.57
Trade value
$88.98K
% of position
0.3%
9/17/2026
496.96K→495.69K
Total
Net shares
−10K
Net value
-$690.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/17/2026 | S · Sale | −8.72K | $69.01 | $601.87K | 1.7% | 505.69K | 496.96K |
| Common Stock Indirect | 9/17/2026 | S · Sale | −1.28K | $69.57 | $88.98K | 0.3% | 496.96K | 495.69K |
| Total | −10K | -$690.85K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned750K
Common Stock
IndirectShares owned3.57M
Common Stock
DirectShares owned243.33K
Total
243.33K direct·4.32M indirect4.56M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 750K | Indirect |
| Common Stock | 3.57M | Indirect |
| Common Stock | 243.33K | Direct |
| Total | 4.56M | 243.33K direct·4.32M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported